FDA Removes Carbetapentane Citrate from Over-the-Counter Drug Regulations

Summary

The Food and Drug Administration (FDA) has amended its regulations to remove carbetapentane citrate from over-the-counter (OTC) drug products, citing a lack of effectiveness at OTC doses, following a 1987 review of OTC drug products.